lobbying_activities: 1071306

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1071306	56e54159-5709-4465-9721-3c82bc242f88	Q1	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2011	first_quarter	HCR	AACC wrote in opposition to H.R. 556, the Preserving Patient Choices Act, which would eliminate section 6301, as amended by sction 10602, of Patient Protections and Affordable Care Act. These provisions are the basis of the new Patient Centered Outcomes Research Institute.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			0	0	2011-04-05T12:14:26.673000-04:00